Seeking Alpha

Shares of Inhibitex (INHX +2.3%) tack on a gain, helped along with a note from Noble Financial's...

Shares of Inhibitex (INHX +2.3%) tack on a gain, helped along with a note from Noble Financial's Nathan Cali to clients saying he believes the firm's INX-189 drug increases the chances of a "lucrative" partnership deal or merger in the future.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|